Insulin glargine, recombinant Subcutaneous and Quinupristin and Dalfopristin
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Quinupristin and Dalfopristin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: dalfopristin / quinupristin
Brand name: Synercid
Synonyms: Dalfopristin and quinupristin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Quinupristin and dalfopristin Intravenous
- Insulin glargine, recombinant Subcutaneous-QuinZyme coenzyme Q-10
- Insulin glargine, recombinant Subcutaneous-Quiphile
- Insulin glargine, recombinant Subcutaneous-Quit Nicotine Gum - Mint
- Insulin glargine, recombinant Subcutaneous-Qutenza
- Insulin glargine, recombinant Subcutaneous-Qvar
- Quinupristin and Dalfopristin-Insulin glulisine
- Quinupristin and Dalfopristin-Insulin Glulisine (Cartridges and Pens)
- Quinupristin and Dalfopristin-Insulin Glulisine (Vials)
- Quinupristin and Dalfopristin-Insulin glulisine Subcutaneous
- Quinupristin and Dalfopristin-Insulin human inhaled Inhalation
- Quinupristin and Dalfopristin-Insulin human regular Injection